FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Mylan Pharmaceuticals Norethindrone Acetate and Ethinyl Estradiol Recall

Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0

Mylan Pharmaceuticals Inc. · Morgantown, WV

Risk level
Class III
Reported by FDA
May 31, 2017
Recall ID
D-0861-2017
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Norethindrone Acetate and Ethinyl Estradiol starting Jan 30, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0861-2017 on May 31, 2017. Reason: Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room. Status: Terminated.

Why it was recalled

Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.

Product description

Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tablets (NDC 0378-7280-85), packaged in 3 pouches, each contains one blister pack of 21 tablets (NDC 0378-7280-53), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India.

Lot numbers, UPCs & expiration codes

Lot #: 6327A006, Exp 02/18

Where it was sold

Nationwide in USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0861-2017
Classification
Class III
Status
Terminated
Recall initiated
Jan 30, 2017
FDA report date
May 31, 2017
Quantity
8,605 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0861-2017, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Terminated
Country
United States
Event ID
77065
Address
781 Chestnut Ridge Rd
Code information
Lot #: 6327A006, Exp 02/18
Postal code
26505-2730
Report date
May 31, 2017
Product type
Drugs
Recall number
D-0861-2017
Classification
Class III
Recalling firm
Mylan Pharmaceuticals Inc.
Product quantity
8,605 cartons
Termination date
Jun 1, 2017
Reason for recall
Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tablets (NDC 0378-7280-85), packaged in 3 pouches, each contains one blister pack of 21 tablets (NDC 0378-7280-53), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India.
Distribution pattern
Nationwide in USA
Recall initiation date
Jan 30, 2017
Initial firm notification
E-Mail
Center classification date
May 23, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0861-2017, published May 31, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls